Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens
about
Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphateUse of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsPharmacokinetics of clindamycin in pregnant women in the peripartum period.Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilisIssues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MICAnti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malariaIn vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.Antimicrobial therapy for the elderly patient.Interethnic differences in pharmacokinetics of antibacterials.Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.Protein binding of clindamycin in sera of patients with AIDS.Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients.Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.Effects of altered plasma alpha-1-acid glycoprotein levels on pharmacokinetics of some basic antibiotics in pigs: simulation analysis.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).Treatment of contaminated bone defects with clindamycin-reconstituted bone xenograft-composites.AUIC--a general target for the optimization of dosing regimens of antibiotics?Meta-analysis of parenteral clindamycin dosing regimens.
P2860
Q28359157-F4120E13-BF61-453D-90C9-185C62BF95FBQ30832465-1661DA50-0B5A-4BAC-9197-5B9D19731D6FQ33826411-0AB58B20-6508-4A77-A97E-5EB5689578B0Q34299078-EC71C4E9-4F76-4D73-961A-8B7607EB8900Q35126312-EE4EEF19-0FFE-4545-AA51-9833C64F4698Q35133942-87431ED9-FFF1-49BE-B1C0-266EAD73603EQ35637864-F434C3F2-3EAE-4E39-8177-76AA1B10B73BQ35690192-2DCD63D7-4B6B-424E-BD49-BCBC96BFC082Q35850868-AAE31F50-2D4B-425A-8076-61B9D9640A45Q36018672-B1575D48-F1D2-45F3-9397-F57A429D3F1CQ36072639-78B78F6E-F186-4ABB-A7E4-750118EE643FQ36307045-EFDF5116-0CD5-49B7-AA5D-B8CBA2C9BD18Q38006505-AC3AF42A-4257-4E11-B1A2-A346204176CBQ38266806-26C68E11-2D5A-4B0B-AC94-A54DB674755FQ38627882-3796AFA6-1407-4DAF-9B9A-A13107239A03Q39782007-82EF24C7-498D-4F6C-AA91-21DAA657135EQ39866037-1AE8FDE6-8786-451F-8999-47C18214EC57Q40722812-E371B4E1-CED3-48A0-AE9C-D4B43ECA6DA8Q41359629-BE84269E-D165-4B9E-BFCE-9C3CBC09455AQ43923580-3568A20F-6121-46B6-BFB8-17D7856109A5Q47396324-2432E180-97EA-42D5-B933-2CD4E317A922Q50908347-0CF894C4-6BB4-4E81-8BBB-CD2BE5257D07Q52298024-C5E92EF4-06F8-4A25-B406-C9C68B6948DBQ53373302-72B0FB2F-7B5B-4868-A4E0-3DEAB8ED7558
P2860
Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Comparative pharmacokinetics a ...... n in different dosing regimens
@ast
Comparative pharmacokinetics a ...... n in different dosing regimens
@en
type
label
Comparative pharmacokinetics a ...... n in different dosing regimens
@ast
Comparative pharmacokinetics a ...... n in different dosing regimens
@en
prefLabel
Comparative pharmacokinetics a ...... n in different dosing regimens
@ast
Comparative pharmacokinetics a ...... n in different dosing regimens
@en
P2093
P2860
P356
P1476
Comparative pharmacokinetics a ...... n in different dosing regimens
@en
P2093
Flaherty JF
Fleishaker JC
Gambertoglio JG
Guglielmo BJ
Rodondi LC
Townsend RJ
P2860
P304
P356
10.1128/AAC.32.12.1825
P407
P577
1988-12-01T00:00:00Z